Login

LIFECORE BIOMEDICAL INC SEC Filings

Filed On Filing
12 Nov 2024 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
02 Jul 2024 SC 13D/A
11 Jan 2024 SC 13D/A
11 Jan 2023 Form 4: Wynnefield Partners Small Cap Value Lp I, 10% owner and 7 others

Acquired 3,250 Series A Convertible Preferred Stock (Open Market Purchase) ($3.25M)

29 Nov 2022 Form 4: Wynnefield Partners Small Cap Value Lp I, 10% owner and 7 others

Bought 627,746 shares ($5M)

13 Feb 2009 AMENDMENT TO SCHEDULE 13G
10 Apr 2008 LIFECORE BIOMEDICAL INC 13GA2
07 Apr 2008 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
28 Mar 2008 EFFECT
28 Mar 2008 EFFECT
28 Mar 2008 EFFECT
28 Mar 2008 EFFECT
28 Mar 2008 EFFECT
28 Mar 2008 Form 4: Runnells John E, Director

Disposed of 65,000 Non-Qualified Stock Option (Disposition to Issuer) ($393K)

27 Mar 2008 Form 4: Emerson Martin J, Director

Disposed of 18,750 Stock Option (Right to Buy) (Disposition to Issuer) ($44.3K)

27 Mar 2008 Form 4: Thacker Kipling, VP of New Business Development

Disposed of 24,550 Common Stock (Right to Buy) (Disposition to Issuer) ($155K) · Disposed of 30,000 Common Stock (Disposition to Issuer) ($186K)

27 Mar 2008 Form 4: Perkins Richard W, Director

Disposed of 17,500 Stock Option (Right to Buy) (Disposition to Issuer) ($96.3K)

27 Mar 2008 Form 4: Noel David M, CFO & VP of Finance

Disposed of 83,500 Stock Option (Right to Buy) (Disposition to Issuer) ($722K)

27 Mar 2008 Form 4: Hiebert Larry D, VP Operations

Disposed of 73,050 Stock Option (Right to Buy) (Disposition to Issuer) ($725K) · Disposed of 17,500 Stock Option (RIght to Buy) (Disposition to Issuer) ($74.6K)

27 Mar 2008 Form 4: Hall James G, VP Technical Operations

Disposed of 50,125 Stock Option (Right to Buy) (Disposition to Issuer) ($138K) · Disposed of 2,000 Common Stock (Right to Buy) (Disposition to Issuer) ($12.6K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support